Stockreport

Arbutus Biopharma up 3% on planned joint development of Roivant Sciences' nucleic acid delivery platform [Seeking Alpha]

Arbutus Biopharma Corporation  (ABUS) 
Last arbutus biopharma corporation earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arbutusbio.com/node/5806
PDF Arbutus Biopharma up 3% on planned joint development of Roivant Sciences' nucleic acid delivery platformA13D filing by Arbutus Biopharma (ABUS+2.7%) discloses a 29.1% st [Read more]